IRIS
GUIDO, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.781
NA - Nord America 3.430
SA - Sud America 1.471
EU - Europa 1.186
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 181
OC - Oceania 4
Totale 11.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.188
SG - Singapore 2.016
BR - Brasile 1.049
VN - Vietnam 782
CN - Cina 733
IT - Italia 643
HK - Hong Kong 341
BD - Bangladesh 306
FR - Francia 174
KR - Corea 168
AR - Argentina 153
CA - Canada 81
IQ - Iraq 73
MX - Messico 68
EC - Ecuador 65
DE - Germania 64
GB - Regno Unito 60
IN - India 59
CO - Colombia 58
RU - Federazione Russa 56
ZA - Sudafrica 48
NL - Olanda 42
ID - Indonesia 39
CL - Cile 38
PK - Pakistan 35
VE - Venezuela 29
TR - Turchia 27
MA - Marocco 26
TN - Tunisia 25
PY - Paraguay 23
UZ - Uzbekistan 23
FI - Finlandia 22
UA - Ucraina 22
UY - Uruguay 22
ES - Italia 20
MY - Malesia 20
EG - Egitto 19
SA - Arabia Saudita 19
PE - Perù 18
DZ - Algeria 15
PH - Filippine 15
BO - Bolivia 13
JM - Giamaica 13
KZ - Kazakistan 13
CR - Costa Rica 12
NP - Nepal 12
AG - Antigua e Barbuda 11
AZ - Azerbaigian 11
JO - Giordania 11
KE - Kenya 11
SE - Svezia 11
ET - Etiopia 10
PL - Polonia 10
JP - Giappone 9
PA - Panama 9
DO - Repubblica Dominicana 8
PR - Porto Rico 8
BH - Bahrain 7
GT - Guatemala 7
AL - Albania 6
AT - Austria 6
HN - Honduras 6
IR - Iran 6
KW - Kuwait 6
LB - Libano 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
CW - ???statistics.table.value.countryCode.CW??? 5
IE - Irlanda 5
KG - Kirghizistan 5
NI - Nicaragua 5
OM - Oman 5
QA - Qatar 5
SN - Senegal 5
AU - Australia 4
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
CY - Cipro 4
IL - Israele 4
LT - Lituania 4
PS - Palestinian Territory 4
RS - Serbia 4
SV - El Salvador 4
CZ - Repubblica Ceca 3
DK - Danimarca 3
LK - Sri Lanka 3
LY - Libia 3
MD - Moldavia 3
RO - Romania 3
AO - Angola 2
BW - Botswana 2
CG - Congo 2
EE - Estonia 2
GA - Gabon 2
GR - Grecia 2
HU - Ungheria 2
KH - Cambogia 2
LV - Lettonia 2
SR - Suriname 2
Totale 11.030
Salva come PNG Salva come JPEG
Città #
Singapore 750
Council Bluffs 746
San Jose 671
Ashburn 523
Hong Kong 336
Ho Chi Minh City 297
Hefei 272
Beijing 191
Seoul 163
Hanoi 157
Lauterbourg 154
Dallas 137
Milan 125
New York 97
São Paulo 93
Santa Clara 87
Phoenix 74
Rome 47
Los Angeles 43
Da Nang 41
Naples 38
Amsterdam 37
Longmont 35
Rio de Janeiro 35
Miano 29
Atlanta 28
Munich 28
Haiphong 27
Mexico City 27
Baghdad 25
Tianjin 24
Biên Hòa 23
Brasília 22
Rende 22
Dhaka 21
Hải Dương 20
Tashkent 20
Toronto 20
Omaha 19
Guayaquil 18
Johannesburg 18
San Antonio 18
Brooklyn 17
Fortaleza 17
Quito 17
Curitiba 16
Helsinki 16
Irvine 16
Montevideo 16
Belo Horizonte 15
Campinas 15
Chicago 15
Columbus 15
North Bergen 15
Porto Alegre 15
Bogotá 14
Greenville 14
Myrtle Beach 14
San Francisco 14
Bologna 13
Cape Town 13
Medellín 13
Montreal 13
Turin 13
Orem 12
Palermo 12
Santiago 12
Seattle 12
Frankfurt am Main 11
Kuala Lumpur 11
St John's 11
Amman 10
Boston 10
Buffalo 10
Guangzhou 10
Istanbul 10
Lima 10
San José 10
Stockholm 10
Tunis 10
Addis Ababa 9
Baku 9
Buenos Aires 9
Can Tho 9
Chennai 9
Joinville 9
London 9
Nairobi 9
Nova Iguaçu 9
Salvador 9
Shanghai 9
Cairo 8
Carapicuíba 8
Florence 8
Guarulhos 8
Jeddah 8
Karachi 8
Lấp Vò 8
Osasco 8
Panama City 8
Totale 6.226
Salva come PNG Salva come JPEG
Nome #
A State-of-the-Art Review of Ophthalmological Indications for a Cesarean Section: Is There a Patient for Whom a Cesarean Section Is Really Indicated? 150
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 114
Assessment of insulin resistance in lean women with polycystic ovary syndrome 108
A WHO 2021-based comprehensive scheme outlining sperm parameters’ associations with IVF outcomes in PGT-A cycles 106
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 105
A NEW ULTRASOUND CRITERIUM FOR THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME: PREDICTIVITY OF THE STROMA/AREA RATIO 104
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 100
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 99
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 97
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 96
Value of PGT-A when only one or two blastocysts are obtained: propensity-score matching and cost-effectiveness study 95
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 94
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 93
A first stage placental site trophoblastic tumor: a case report and review of literature 92
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 92
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 91
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 91
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 91
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 89
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 85
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 85
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 84
Clinical, obstetric and perinatal outcomes after vitrified-warmed euploid blastocyst transfer are independent of cryo-storage duration 81
Sex ratio at birth: causes of variation and narrative review of literature 81
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 81
Endocrinology: Differential androgen response to adrenocorticotrophin hormone stimulation and effect of opioid antagonist on insulin secretion in polycystic ovarian syndrome 80
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 79
Synchronous ovarian and uterine tumours: a case report of an unusual association 77
Alterazioni funzionali: patogenesi, diagnosi e terapia delle cause ovariche 77
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 77
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 77
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 77
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 77
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 76
Progesterone: The Key Factor of the Beginning of Life 74
Alterazioni della secrezione di GH nella sindrome dell'ovaio policistico: un nuovo fattore fisiopatologico 74
Clinical efficacy and metabolic impact of two different dosages of ethinyl-estradiol with drospirenone in normal weight women with polycystic ovary syndrome 74
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE. 73
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 72
EFFECT OF PIOGLITAZONE TREATMENT ON THE ADRENAL ANDROGEN REPONSE TO CORTICOTROPHIN IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 72
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 72
EFFECT OF THE INSULIN-SENSITIZING DRUG METFORMIN ON THE GROWTH HORMONE RESPONSE TP GROWTH HORMONE RELEASING HORMONE IN OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: RELATIONSHIP WITH FOOD INGESTION 72
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 71
INSULIN RESISTANCE AND WOMEN'S HEALTH 71
Differences in AMH levels in the four polycystic ovary syndrome phenotypes based on Rotterdam criteria 71
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 70
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 70
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 70
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 70
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 70
INSULIN SECRETION IN POLYCYSTIC OVARY DISEASE (PCOD): A MULTIFACTORIAL PROBLEM 70
ADOLESCENTE CON ENDOMETRIOSI E PROSPETTIVE RIPRODUTTIVE 69
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 69
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 68
DETRIMENTAL EFFECT OF AGE ON THE OVARIAN RESPONSE TO GONADOTROPIN AND ON PREGNANCY RATE IN POLYCYSTIC OVARIAN SYNDROME WOMEN 68
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: an euglycaemic-hyperinsulinaemic clamp study 68
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS RESPONSE TO NALAXONE IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME 68
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 68
IS THERE A ROLE FOR ISOLAVONES IN THE THERAPEUTIC APPROCH TO POLYCYSTIC OVARY SYNDROME? RESULTS FROM A PILOT STUDY 67
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 67
VAGINAL MESH REPAIR SYSTEMS FOR PELVIC ORGAN PROLAPSE: ANATOMICAL STUDY COMPARING OUTSIDE-IN VS INSIDE-OUT-TECHNIQUES 66
GH RESPONSE TO FOOD INTAKE IN OBESE pcos WOMEN: EFFECT OF METFORMIN 66
Using a 16-French Resectoscope as an Alternative Device in the Treatment of Uterine Lesions: A Randomized Controlled Trial 65
L'INDUZIONE DELL'OVULAZIONE CON FSH PURIFICATO IN PAZIENTI AFFETTE DA SINDROME DELL'OVAIO POLICISTICO: POSSIBILI VANTAGGI DELLA TERAPIA A BASSE DOSI 65
INFLUENCE OF BODY MASS ON THE HYPOTHALAMIC-PITUITARY-ADRENAL-AXIS RESPONSE TO NALOXONE IN PATIENTS WITH POLYCYSTIC SYNDROME 65
How should the best human embryo in vitro be? Current and future challenges for embryo selection 65
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial. 65
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 64
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 64
PIOGLITAZONE ADMINISTRATION IN HYPERINSULINEMIC WOMEN WITH PCOS DECREASES THE ADRENAL ANDROGEN RESPONSE TO CORTICOTROPHIN-RELEASING FACTOR 63
ENDOSCOPIC SURGERY IN OVARIAN ENDOMETRIOSIS: HISTOPATOLOGIC OBSERVATIONS ON THE LOSS OF FOLLICULAR TISSUE DURING TREATMENT 63
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 63
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 63
ALTERATION OF GHRELIN-NEUROPEPTIDE Y NETWORK IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME: ROLE OF HYPERINSULINISM 63
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 63
METFORMIN TREATMENT DOSE NOT AFFECT TOTAL LEPTIN LEVELS AND FREE LEPTIN INDEX IN OBESE PATIENTS WITH POLYCYSTIC OVARY SYNDROME 62
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations. 62
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 62
TOPICAL HAEMOSTATICS AND SEALANTS IN GYNAECOLOGICAL AND OBSTETRIC 3 SURGERY: STATE OF THE ART 62
RECOMBINANT versus URINARY FOLLICLE STIMULATING HORMONE (FSH) IN THE LOW-DOSE REGIMEN IN ANOVULATORY PATIENTS WITH POLICYSTYC OVARY SYNDROME (PCOS): A SAFER AND MORE EFFECTIVE TREATMENT 62
How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation 61
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy 61
Metformin Effects tin Ovarian Ultrasound Appearance and Steroidogenic Function in Normal Weight, Normoinsulinemic Women with Polycystic Ovary Syndrome: A Randomized, Double Blind, Placebo-Controlled Clinical Trial 61
Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down syndrome 61
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 61
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 61
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 60
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 60
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 60
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 59
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 59
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 59
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 59
Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome 59
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 58
APPROCCIO DIAGNOSTICO ALLA COPPIA STERILE 58
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 58
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 57
OPIOIDS AND GROWTH HORMONE IN POLYCYSTIC OVARY SYNDROME. EFFECT OF FEEDING. 57
ROLE OF GnRH ANALOG PITUITARY DESENSITIZATION IN INDUCTION OF OVULATION IN POLYCYSTIC OVARIAN SYNDROME 57
Totale 7.388
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.004
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.004
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20231 0 0 0 0 0 0 1 0 0 0 0 0
2023/20243 0 0 0 0 0 1 0 0 1 0 0 1
2024/20251.724 0 2 1 0 215 197 103 73 302 113 140 578
2025/20267.450 1.034 379 303 770 1.347 508 791 340 417 543 473 545
2026/20272.077 420 143 467 1.047 0 0 0 0 0 0 0 0
Totale 11.255